Logo image of MPW

MEDICAL PROPERTIES TRUST INC (MPW) Stock Fundamental Analysis

USA - NYSE:MPW - US58463J3041 - REIT

4.9225 USD
+0.07 (+1.49%)
Last: 9/16/2025, 11:39:04 AM
Fundamental Rating

4

Taking everything into account, MPW scores 4 out of 10 in our fundamental rating. MPW was compared to 130 industry peers in the Diversified REITs industry. While MPW seems to be doing ok healthwise, there are quite some concerns on its profitability. MPW is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year MPW has reported negative net income.
In the past year MPW had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: MPW reported negative net income in multiple years.
Each year in the past 5 years MPW had a positive operating cash flow.
MPW Yearly Net Income VS EBIT VS OCF VS FCFMPW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

1.2 Ratios

The Return On Assets of MPW (-9.45%) is worse than 90.00% of its industry peers.
MPW's Return On Equity of -29.62% is on the low side compared to the rest of the industry. MPW is outperformed by 88.46% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.93%, MPW is doing worse than 66.15% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for MPW is in line with the industry average of 3.05%.
Industry RankSector Rank
ROA -9.45%
ROE -29.62%
ROIC 1.93%
ROA(3y)-5.11%
ROA(5y)-1.92%
ROE(3y)-15.57%
ROE(5y)-6.62%
ROIC(3y)2.26%
ROIC(5y)2.99%
MPW Yearly ROA, ROE, ROICMPW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

Looking at the Operating Margin, with a value of 38.49%, MPW belongs to the top of the industry, outperforming 83.08% of the companies in the same industry.
In the last couple of years the Operating Margin of MPW has declined.
With an excellent Gross Margin value of 96.46%, MPW belongs to the best of the industry, outperforming 97.69% of the companies in the same industry.
In the last couple of years the Gross Margin of MPW has remained more or less at the same level.
Industry RankSector Rank
OM 38.49%
PM (TTM) N/A
GM 96.46%
OM growth 3Y-16.71%
OM growth 5Y-10.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.03%
GM growth 5Y-0.02%
MPW Yearly Profit, Operating, Gross MarginsMPW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

4

2. Health

2.1 Basic Checks

MPW has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for MPW has been increased compared to 1 year ago.
Compared to 5 years ago, MPW has more shares outstanding
The debt/assets ratio for MPW is higher compared to a year ago.
MPW Yearly Shares OutstandingMPW Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
MPW Yearly Total Debt VS Total AssetsMPW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of 0.00, we must say that MPW is in the distress zone and has some risk of bankruptcy.
MPW has a worse Altman-Z score (0.00) than 73.85% of its industry peers.
MPW has a debt to FCF ratio of 931.91. This is a negative value and a sign of low solvency as MPW would need 931.91 years to pay back of all of its debts.
The Debt to FCF ratio of MPW (931.91) is comparable to the rest of the industry.
A Debt/Equity ratio of 2.00 is on the high side and indicates that MPW has dependencies on debt financing.
MPW's Debt to Equity ratio of 2.00 is on the low side compared to the rest of the industry. MPW is outperformed by 70.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 2
Debt/FCF 931.91
Altman-Z 0
ROIC/WACC0.3
WACC6.34%
MPW Yearly LT Debt VS Equity VS FCFMPW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

A Current Ratio of 2.07 indicates that MPW has no problem at all paying its short term obligations.
The Current ratio of MPW (2.07) is better than 82.31% of its industry peers.
MPW has a Quick Ratio of 2.07. This indicates that MPW is financially healthy and has no problem in meeting its short term obligations.
MPW has a better Quick ratio (2.07) than 82.31% of its industry peers.
Industry RankSector Rank
Current Ratio 2.07
Quick Ratio 2.07
MPW Yearly Current Assets VS Current LiabilitesMPW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

MPW shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -820.83%.
MPW shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.66%.
MPW shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.11% yearly.
EPS 1Y (TTM)-820.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%103.7%
Revenue 1Y (TTM)27.66%
Revenue growth 3Y-13.62%
Revenue growth 5Y3.11%
Sales Q2Q%-9.83%

3.2 Future

The Earnings Per Share is expected to grow by 27.85% on average over the next years. This is a very strong growth
MPW is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.71% yearly.
EPS Next Y97.02%
EPS Next 2Y43.59%
EPS Next 3Y27.85%
EPS Next 5YN/A
Revenue Next Year-3.84%
Revenue Next 2Y1.34%
Revenue Next 3Y3.05%
Revenue Next 5Y2.71%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
MPW Yearly Revenue VS EstimatesMPW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
MPW Yearly EPS VS EstimatesMPW Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

3

4. Valuation

4.1 Price/Earnings Ratio

MPW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 30.15, MPW can be considered very expensive at the moment.
MPW's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MPW is cheaper than 77.69% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.77. MPW is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 30.15
MPW Price Earnings VS Forward Price EarningsMPW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MPW indicates a slightly more expensive valuation: MPW is more expensive than 63.08% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MPW is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 285.77
EV/EBITDA 15.84
MPW Per share dataMPW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MPW's earnings are expected to grow with 27.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.59%
EPS Next 3Y27.85%

5

5. Dividend

5.1 Amount

MPW has a Yearly Dividend Yield of 6.94%, which is a nice return.
Compared to an average industry Dividend Yield of 6.66, MPW pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, MPW pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.94%

5.2 History

The dividend of MPW decreases each year by -10.38%.
MPW has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-10.38%
Div Incr Years0
Div Non Decr Years0
MPW Yearly Dividends per shareMPW Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

MPW has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-16.42%
EPS Next 2Y43.59%
EPS Next 3Y27.85%
MPW Yearly Income VS Free CF VS DividendMPW Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

MEDICAL PROPERTIES TRUST INC

NYSE:MPW (9/16/2025, 11:39:04 AM)

4.9225

+0.07 (+1.49%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners59.89%
Inst Owner Change-2.46%
Ins Owners17.3%
Ins Owner Change10.69%
Market Cap2.96B
Analysts51.76
Price Target4.95 (0.56%)
Short Float %33.45%
Short Ratio18.51
Dividend
Industry RankSector Rank
Dividend Yield 6.94%
Yearly Dividend0.54
Dividend Growth(5Y)-10.38%
DP-16.42%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-11 2025-09-11 (0.08)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5843.9%
Min EPS beat(2)-11757.5%
Max EPS beat(2)69.68%
EPS beat(4)1
Avg EPS beat(4)-3817.81%
Min EPS beat(4)-11757.5%
Max EPS beat(4)69.68%
EPS beat(8)2
Avg EPS beat(8)-1947.02%
EPS beat(12)3
Avg EPS beat(12)-1329.14%
EPS beat(16)7
Avg EPS beat(16)-980.66%
Revenue beat(2)1
Avg Revenue beat(2)-0.71%
Min Revenue beat(2)-3.58%
Max Revenue beat(2)2.15%
Revenue beat(4)2
Avg Revenue beat(4)-1.37%
Min Revenue beat(4)-9.56%
Max Revenue beat(4)5.51%
Revenue beat(8)4
Avg Revenue beat(8)-0.64%
Revenue beat(12)5
Avg Revenue beat(12)-1.65%
Revenue beat(16)6
Avg Revenue beat(16)-1.31%
PT rev (1m)-2.86%
PT rev (3m)-6.85%
EPS NQ rev (1m)-7.71%
EPS NQ rev (3m)9.11%
EPS NY rev (1m)-77.27%
EPS NY rev (3m)-457.14%
Revenue NQ rev (1m)-0.76%
Revenue NQ rev (3m)-1.48%
Revenue NY rev (1m)-0.59%
Revenue NY rev (3m)-1.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 30.15
P/S 3.21
P/FCF 285.77
P/OCF 15.74
P/B 0.61
P/tB 0.61
EV/EBITDA 15.84
EPS(TTM)-2.21
EYN/A
EPS(NY)0.16
Fwd EY3.32%
FCF(TTM)0.02
FCFY0.35%
OCF(TTM)0.31
OCFY6.35%
SpS1.53
BVpS8.04
TBVpS8.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.45%
ROE -29.62%
ROCE 2.45%
ROIC 1.93%
ROICexc 2%
ROICexgc 2.08%
OM 38.49%
PM (TTM) N/A
GM 96.46%
FCFM 1.12%
ROA(3y)-5.11%
ROA(5y)-1.92%
ROE(3y)-15.57%
ROE(5y)-6.62%
ROIC(3y)2.26%
ROIC(5y)2.99%
ROICexc(3y)2.3%
ROICexc(5y)3.06%
ROICexgc(3y)2.37%
ROICexgc(5y)3.14%
ROCE(3y)2.86%
ROCE(5y)3.79%
ROICexcg growth 3Y-18.25%
ROICexcg growth 5Y-8.72%
ROICexc growth 3Y-18.71%
ROICexc growth 5Y-8.92%
OM growth 3Y-16.71%
OM growth 5Y-10.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.03%
GM growth 5Y-0.02%
F-Score4
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 2
Debt/FCF 931.91
Debt/EBITDA 12.68
Cap/Depr 43.72%
Cap/Sales 19.27%
Interest Coverage 0.92
Cash Conversion 24.7%
Profit Quality N/A
Current Ratio 2.07
Quick Ratio 2.07
Altman-Z 0
F-Score4
WACC6.34%
ROIC/WACC0.3
Cap/Depr(3y)171.64%
Cap/Depr(5y)740.47%
Cap/Sales(3y)50.73%
Cap/Sales(5y)169.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-820.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%103.7%
EPS Next Y97.02%
EPS Next 2Y43.59%
EPS Next 3Y27.85%
EPS Next 5YN/A
Revenue 1Y (TTM)27.66%
Revenue growth 3Y-13.62%
Revenue growth 5Y3.11%
Sales Q2Q%-9.83%
Revenue Next Year-3.84%
Revenue Next 2Y1.34%
Revenue Next 3Y3.05%
Revenue Next 5Y2.71%
EBIT growth 1Y54.29%
EBIT growth 3Y-28.05%
EBIT growth 5Y-7.83%
EBIT Next Year121.84%
EBIT Next 3Y36.08%
EBIT Next 5Y20.65%
FCF growth 1Y116.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-69.04%
OCF growth 3Y-32.88%
OCF growth 5Y-13.06%